nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
1 |
Abuse-deterrent formulations: transitioning the pharmaceutical market to improve public health and safety
|
Simon, Kyle |
|
2015 |
|
2 |
p. 67-79 |
artikel |
2 |
Adverse drug reactions due to cancer chemotherapy in a tertiary care teaching hospital
|
Wahlang, Julie Birdie |
|
2017 |
|
2 |
p. 61-66 |
artikel |
3 |
Antiepileptic drugs in women with epilepsy during pregnancy
|
Gedzelman, Evan |
|
2012 |
|
2 |
p. 71-87 |
artikel |
4 |
Antipsychotic drugs in pregnancy: a review of their maternal and fetal effects
|
Galbally, Megan |
|
2014 |
|
2 |
p. 100-109 |
artikel |
5 |
Bleeding risk with systemic thrombolytic therapy for pulmonary embolism: scope of the problem
|
Daley, Mitchell J. |
|
2015 |
|
2 |
p. 57-66 |
artikel |
6 |
Cardiovascular risk with DPP-4 inhibitors: latest evidence and clinical implications
|
Karagiannis, Thomas |
|
2016 |
|
2 |
p. 36-38 |
artikel |
7 |
Community pharmacists’ knowledge and perceptions about adverse drug reactions and barriers towards their reporting in Eastern region, Alahsa, Saudi Arabia
|
Khan, Tahir M. |
|
2013 |
|
2 |
p. 45-51 |
artikel |
8 |
Contemporary utilization of antithrombotic therapy for stroke prevention in patients with atrial fibrillation: an audit in an Australian hospital setting
|
Pandya, Ekta Yogeshkumar |
|
2018 |
|
2 |
p. 97-111 |
artikel |
9 |
Curse of the ghost pills: the role of oral controlled-release formulations in the passage of empty intact shells in faeces. Two case reports and a literature review relevant to psychiatry
|
Tungaraza, Tongeji Elifazi |
|
2013 |
|
2 |
p. 63-71 |
artikel |
10 |
Does design matter? Systematic evaluation of the impact of analytical choices on effect estimates in observational studies
|
Madigan, David |
|
2013 |
|
2 |
p. 53-62 |
artikel |
11 |
Does orlistat cause acute kidney injury?
|
Beyea, Michael M. |
|
2012 |
|
2 |
p. 53-57 |
artikel |
12 |
Drug-induced falls in older persons: is there a role for therapeutic drug monitoring?
|
Hartholt, Klaas A. |
|
2016 |
|
2 |
p. 39-42 |
artikel |
13 |
Drug-induced liver injury in older adults
|
Mitchell, Sarah J. |
|
2010 |
|
2 |
p. 65-77 |
artikel |
14 |
Editorial
|
Mallarkey, Gordon |
|
2010 |
|
2 |
p. 45-52 |
artikel |
15 |
Efficacy and safety of the target-specific oral anticoagulants for stroke prevention in atrial fibrillation: the real-life evidence
|
Russo, Vincenzo |
|
2017 |
|
2 |
p. 67-75 |
artikel |
16 |
Influence of stroke and bleeding risk on prescribing of oral anticoagulants in older inpatients; has the availability of direct oral anticoagulants changed prescribing?
|
Farinola, Nicholas |
|
2018 |
|
2 |
p. 113-121 |
artikel |
17 |
Interventions to reduce medication errors in neonatal care: a systematic review
|
Nguyen, Minh-Nha Rhylie |
|
2018 |
|
2 |
p. 123-155 |
artikel |
18 |
Medication-overuse headache: epidemiology, diagnosis and treatment
|
Kristoffersen, Espen Saxhaug |
|
2014 |
|
2 |
p. 87-99 |
artikel |
19 |
Menopausal hormone therapy and breast cancer mortality: clinical implications
|
Chlebowski, Rowan T. |
|
2015 |
|
2 |
p. 45-56 |
artikel |
20 |
On the integration and standardization of medication error data: taxonomies, terminologies, causes and contributing factors
|
Adham Taib, Ibrahim |
|
2010 |
|
2 |
p. 53-63 |
artikel |
21 |
Pharmacogenomic substudies of randomized controlled trials: consideration of safety outcomes
|
Sorich, Michael J. |
|
2014 |
|
2 |
p. 62-66 |
artikel |
22 |
Polypills for the secondary prevention of cardiovascular disease: effective in improving adherence but are they safe?
|
Selak, Vanessa |
|
2018 |
|
2 |
p. 157-162 |
artikel |
23 |
Published cases of adverse drug reactions: has the quality of reporting improved over time?
|
Kane-Gill, Sandra L. |
|
2015 |
|
2 |
p. 38-44 |
artikel |
24 |
Recent advances in the utility and use of the General Practice Research Database as an example of a UK Primary Care Data resource
|
Williams, Tim |
|
2012 |
|
2 |
p. 89-99 |
artikel |
25 |
Response to treatment and adverse events associated with use of recombinant activated factor VII in children: a retrospective cohort study
|
Cooper, James D. |
|
2017 |
|
2 |
p. 51-59 |
artikel |
26 |
Risks and benefits with bevacizumab: evidence and clinical implications
|
Kurkjian, Carla |
|
2012 |
|
2 |
p. 59-69 |
artikel |
27 |
Safety evaluation and risk assessment of electronic cigarettes as tobacco cigarette substitutes: a systematic review
|
Farsalinos, Konstantinos E. |
|
2014 |
|
2 |
p. 67-86 |
artikel |
28 |
Systems that prevent unwanted represcription of drugs withdrawn because of adverse drug events: a systematic review
|
van der Linden, Carolien M.J. |
|
2013 |
|
2 |
p. 73-90 |
artikel |
29 |
Use of doripenem and risk of seizure and renal impairment in US hospitalized patients: a retrospective cohort study
|
Chavers, Scott |
|
2016 |
|
2 |
p. 43-57 |
artikel |